ArQule initiates dosing in Phase I cancer trial
The primary objective of the company’s Phase I trial with ARQ 621 is to determine its safety, tolerability and recommended Phase II dose. Patients with metastatic solid tumors

The primary objective of the company’s Phase I trial with ARQ 621 is to determine its safety, tolerability and recommended Phase II dose. Patients with metastatic solid tumors

Brian Webster, president of Physio-Control, said: “With the Lifepak 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so

Ms Falberg is currently CFO and COO of Arca biopharma and has over 20 years of experience as a financial executive and corporate director. Ms Falberg’s career includes

For a period of up to five years, the Sanofi-Aventis regenerative medicine program (SARP) will sponsor institute-wide discovery grants in promising research areas that address the organizations’ mutual

Prior to joining MacroGenics, Mr Risser served as senior director of business development at Johnson & Johnson Pharmaceuticals, which he joined in 2003. Before Johnson & Johnson, Mr

Lannett is currently conducting an internal and external search for a permanent CFO. Prior to joining Lannett, Mr Ruck served as corporate controller of Optium. Earlier, Mr Ruck

Dr Boehm is currently employed as vice president of product development at Actavis Pharmaceuticals and is expected to commence employment with Acura in May 2009. Andy Reddick, president

The Biotechnology Industry Organization (BIO) President James Greenwood said: Arizona’s scientists and citizens are missing out on a potential lucrative source of research funds and medical benefits because

For the year 2008, cost of sales increased by $161,917. The increase is related to the increased sales during the year 2008. Sales and Marketing Expenses For the

“Diagnostic tests add value to the health care system by enabling more accurate and targeted treatments for patients and by detecting disease earlier when successful treatment can be